INSECTICIDES (INDIA) LTD.

Insecticides (India) Ltd has announced a Board Meeting scheduled for November 5, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Concurrently, the trading window for dealing in the company's securities will be closed from October 1, 2026, until 48 hours after the declaration of these financial results, as per SEBI regulations and the company's insider trading code.

Insecticides (India) Ltd has announced a Board of Directors meeting scheduled for November 5, 2026. The meeting will inter alia consider and approve the Unaudited Standalone and Consolidated financial results for the quarter and half-year ended September 30, 2026. Additionally, the company will approve the closure of the trading window for designated persons from October 1, 2026, until 48 hours after the declaration of financial results.

Insecticides (India) Limited (IIL) announced its unaudited financial results for Q1FY27, reporting a revenue of ₹612 crore, a 12% decrease compared to ₹691 crore in Q1FY26. This decline is primarily attributed to a rainfall deficit across India. Despite the revenue dip, Gross Profit margins expanded by 240 bps year-on-year due to disciplined pricing. The company also launched GRANUVIA, a next-generation insecticide in collaboration with Corteva Agriscience, and Spinoace. KAEROS continued its growth trajectory. IIL plans to double its Crop Solutions plots to 72. Profit After Tax stood at ₹44 crore, down from ₹58 crore in the prior year.

Insecticides (India) Ltd announced its unaudited standalone financial results for the first quarter ended June 30, 2026. The company reported a total income of ₹62,110.58 Lakhs (₹621.11 Cr) for the quarter, a significant increase from ₹43,275.89 Lakhs (₹432.76 Cr) in the same period last year. Profit before tax stood at ₹5,626.47 Lakhs (₹56.26 Cr), up from ₹1,870.24 Lakhs (₹18.70 Cr) year-on-year. Net profit for the quarter was ₹4,183.05 Lakhs (₹41.83 Cr), compared to ₹1,436.37 Lakhs (₹14.36 Cr) in the prior year's first quarter. Earnings per share (EPS) for the quarter was ₹14.38, an increase from ₹4.94 in the corresponding quarter of the previous year. The results were approved by the Board of Directors after review by the Audit Committee and a limited review by the statutory auditors.

Insecticides (India) Ltd's consolidated Q1 FY27 (June 2026) print missed the growth management had guided for at the Q4 FY26 call — where it had flagged "cautious optimism" for top-line and bottom-line growth "visible from Q1." Instead, consolidated revenue from operations fell 11.5% YoY to ₹611.5 Cr (from ₹691.1 Cr) and PAT fell 24.5% YoY to ₹43.9 Cr (from ₹58.1 Cr, EPS ₹15.08 vs ₹19.97), a clear miss against that outlook. No consensus/street estimate for this specific quarter could be found in a web search, so vsStreet is unknown rather than assumed. Margins compressed on both counts: net margin fell to roughly 7.2% from 8.4% a year ago, and operating margin to about 11.1% from 12.2%. The squeeze sits below the gross-margin line — cost of materials consumed was actually down ~3.9% YoY — and instead comes from finance costs (+26% YoY to ₹4.69 Cr) and depreciation (+33% YoY to ₹9.71 Cr) rising well ahead of revenue, alongside a >2x jump in purchased stock-in-trade (₹106.96 Cr vs ₹45.10 Cr) that points to a heavier reliance on bought-out/job-work formulations this quarter rather than in-house volume growth. The sequential comparison looks strong — revenue up ~43% and PAT up ~275% QoQ against a seasonally weak Q4 (Jan-Mar is agrochemical off-season; June-quarter demand tracks kharif sowing) — but that is a seasonality artifact typical of the sector and not a trend signal; the YoY decline is the number that matters. Consolidated results include two subsidiaries, IIL Biologicals and Kaeros Research (formerly Kaeros Research Private Ltd), which together contributed ₹57.1 Cr revenue and ₹2.9 Cr PAT this quarter per the auditors' other-matters note — an early, still-small read on whether Kaeros can deliver the "significant future growth" management pointed to at the last call. Standalone PAT of ₹41.8 Cr against consolidated ₹43.9 Cr reflects that subsidiary/JV contribution; no company press release commentary was available in the source context to cross-check management's own framing of the quarter.

Insecticides (India) Ltd has announced that its Board of Directors will convene on August 11, 2026. The primary agenda item is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. Concurrently, the company has confirmed the closure of the trading window for insiders from July 1, 2026, until 48 hours after the financial results are declared, in compliance with SEBI regulations. The information will also be available on the company's website.

Insecticides (India) Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26, as required by SEBI regulations. The report, an integral part of the Annual Report, details the company's performance and commitments in environmental, social, and governance aspects. The company's primary business activity is the manufacturing and trading of Agro-Chemicals, contributing 100% to its turnover. Key products include insecticides (49% of turnover), herbicides (37%), fungicides (10%), and biologicals & plant growth regulators (4%). The company operates 8 plants and 43 offices nationally, serving 30 states and 22 countries, with exports accounting for 5% of total turnover. The BRSR report is available on their website.

Insecticides (India) Ltd has announced its 29th Annual General Meeting (AGM) will be held on Wednesday, August 12, 2026, at 03:00 PM via Video Conferencing/OAVM. The company is providing a remote e-voting facility for its members from August 8 to August 11, 2026. The cut-off date for eligibility to vote is August 5, 2026. The Annual Report for FY 2025-26, including the AGM Notice and Business Responsibility and Sustainability Report (BRSR), has been dispatched electronically and is available on the company's website.

Insecticides (India) Limited has announced its 29th Annual General Meeting (AGM) will be held on Wednesday, August 12, 2026, at 03:00 PM via Video Conferencing (VC)/OAVM. The company is offering a remote e-voting facility for its members from August 8 to August 11, 2026. The cut-off date for e-voting eligibility is August 5, 2026. The Annual Report for FY 2025-26, including the AGM Notice and Business Responsibility and Sustainability Report (BRSR), has been dispatched electronically and is available on the company's website.

Insecticides (India) Limited has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in accordance with the company's code of conduct for prohibition of insider trading and SEBI regulations. The trading window will be shut from July 01, 2026, until 48 hours after the declaration of financial results for the quarter ended June 30, 2026. The specific date for the board meeting to approve these unaudited financial results will be communicated later. This measure is to prevent potential insider trading activities.